BioConsortia Closes Financing to Accelerate Launch of Next-Generation Nitrogen-Fixing Biofertilizer and Fuel Global Expansion
'This investment, one in a series of recurring financings from our internal investors, reflects their deep confidence in BioConsortia's science, strategy, and commercial momentum,' said Marcus Meadows-Smith, BioConsortia's CEO. 'Their investments total $95 million and bring BioConsortia to this exciting moment in the company's history.'
The new funding will accelerate the global launch of Always-N™, BioConsortia's groundbreaking nitrogen-fixing seed treatment for industrial corn and support continued expansion of its discovery and development engine at the company's Davis, California headquarters.
Always-N enables farmers to maintain crop yields while reducing reliance on synthetic nitrogen fertilizers—significantly lowering greenhouse gas emissions and improving soil health. Applied as a seed treatment, Always-N delivers consistent field performance and is the only nitrogen-fixing biofertilizer combining advanced gene editing and extended viability exceeding two years.
"Synthetic nitrogen fertilizers are essential to modern agriculture, but their overuse comes at a steep environmental cost,' said Meadows-Smith. 'With Always-N, we offer a powerful, sustainable alternative—backed by cutting-edge science and built for real-world performance.'
Roughly half of applied synthetic nitrogen is never absorbed by crops. Instead, it runs off into waterways or is broken down in soil, releasing nitrous oxide—a greenhouse gas 300 times more potent than CO₂. As regulatory and market pressure builds for climate-smart farming, demand for sustainable alternatives like Always-N is growing rapidly.
Following its successful commercial debut in New Zealand in 2024, Always-N is now preparing for broader market entry, supported by key global partners including The Mosaic Company in row crops in the Americas. The new funding enables BioConsortia to scale manufacturing, build inventory, and expand market access in anticipation of the upcoming growing season.
Always-N is powered by BioConsortia's discovery and development platform - an integrated engine using proprietary tools for microbial discovery, selection, and optimization. It begins with Advanced Microbial Selection™ (AMS) to identify high-performing plant-associated microbes, then uses GenExpress™ and GenePro™ tools to enhance traits such as nitrogen fixation, disease and pest control, and shelf-life.
In addition to Always-N™, BioConsortia is advancing a robust pipeline of next-generation biostimulants, fungicides, nematicides, and insecticides—engineered for extended shelf life, ease of use, and superior field efficacy.
Since its founding in 2014, BioConsortia has validated its platform across diverse crops, geographies, and soil types. Field trials have consistently demonstrated the efficacy of its microbial biofertilizers, fungicides, nematicides, and insecticides—delivering growers new tools for sustainable, high-yield farming.
About BioConsortia
At BioConsortia, we are pioneering the next generation of agricultural biologicals through cutting-edge microbial gene editing. Our breakthroughs in editing only the most stable microbes unlock unprecedented performance in nitrogen fixation, biocontrol, and biostimulants—delivering solutions that are more effective, more consistent, and easier to use than anything on the market today. By precisely enhancing natural microbial traits, we're creating products that outperform both traditional chemicals and first-generation biologicals—with longer shelf life, extended life on seed, robust field efficacy, and compatibility with existing farm systems. Our AMS platform supports rapid discovery and development of superior wild type microbial products, and our gene-edited innovations redefine what's possible in sustainable agriculture.
Since its founding in 2014, BioConsortia has built a reputation for delivering science-driven, field-proven solutions across a wide range of crops, geographies, and growing conditions. Today, the company stands at the forefront of the agricultural biologicals revolution—offering farmers the tools to grow more with less, and do so sustainably.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
25 minutes ago
- Business Wire
Bone Solutions Announces Five New Patents Awarded in FY25, Further Enhancing Its Core Mg OSTEOCRETE Technology
COLLEYVILLE, Texas--(BUSINESS WIRE)-- Bone Solutions Inc., an orthobiologics technology company located in Colleyville, Texas, announced today its fifth patent awarded this year from the U.S. Patent and Trademark Office (USPTO) related to Mg OSTEOCRETE, a portfolio of patents that includes current and future configurations, as well as novel delivery systems. "Bone Solutions is furthering its mission to improve patient outcomes." These five patents further expand Bone Solutions' industry footprint and allow surgeons and patients to further benefit from the advantages of the Bone Solutions proprietary magnesium-based technology. Mg OSTEOCRETE and Mg OSTEOINJECT (an injectable version of the product) are fast-setting bone substitutes that remodel into bone over time through creeping substitution, meaning they provide needed support to the defect or void during the healing process while transforming into bone at an optimal rate. 'We are pleased to announce the addition of five new patents supplementing our various technologies, ensuring our continued growth and profitability for the company's future,' said Drew Diaz, CEO of Bone Solutions. 'By leveraging our existing technology, Bone Solutions is furthering its mission to improve patient outcomes through our superior magnesium-based orthopedic solutions." The magnesium component of Mg OSTEOCRETE is the significant differentiator from other bone substitutes on the market. The crystallization reaction from magnesium oxide and the blend of phosphate-based materials allows for ideal osteoconductivity of the product. As a result, Mg OSTEOCRETE and Mg OSTEOINJECT set and cure in situ without migration. The material stimulates cell adhesion, proliferation, and formation of the bone extracellular matrix by osteoblast cells, thus promoting bone growth. In addition to the superior biological performance of the material, the handling characteristics and formulation are ideal for clinical use. Ready for use after only 30 seconds of mixing, the material is moldable or injectable and is cohesive and adhesive to the area it fills. Once implanted, the material sets quickly, is drillable after only two minutes, and is also radiopaque. Mg OSTEOCRETE and Mg OSTEOINJECT are currently being distributed to facilities and surgical centers nationwide for immediate clinical use. About Bone Solutions Inc. Bone Solutions Inc. is a specialized medical device company dedicated to improving clinical outcomes through biologically safe, fully resorbable magnesium-based orthopedic implant solutions, with a focus on addressing complex procedures and cost reduction. The company is developing various new orthopedic technologies within its FDA-cleared magnesium-based platform.
Business Wire
25 minutes ago
- Business Wire
Cade Museum Co-Founder Phoebe Cade Miles Featured on Forbes' '50 Over 50' List
GAINESVILLE, Fla.--(BUSINESS WIRE)--Cade Museum co-founder and board chair Phoebe Cade Miles has been featured in Forbes' new '50 Over 50' list of women who have not only made great accomplishments in their careers, but who are creating their greatest achievements after the age of 50. "My advice for anyone nearing the half-century mark is that your most significant contributions are likely to be ahead of you, not behind you!' Share Forbes recently released the 2025 ' 50 Over 50 ' list in conjunction with Mika Brzezinski, the founder of Know Your Value and co-host of MSNBC's Morning Joe. The list comprises 200 women in four different categories – lifestyle, impact, innovation and investment – and highlights entrepreneurs, innovators and artists who are changing the world, and doing so in the second half of their lives. Recognized for inspiring and equipping future inventors and visionaries through the Cade Museum for Creativity and Invention and the annual Cade Prize for Inventivity competition for early-stage inventors, Miles amplifies her father's passion for science, the arts, and pursuing big ideas. Best known as the lead inventor of Gatorade, Dr. Robert Cade was a curious Renaissance man who thought, and taught, outside the box. His daughter, Phoebe Cade Miles, aims to inspire and educate the way he did. Miles is honored to be included in the list because to her, 'it celebrates the wisdom that comes with growing older,' she said. Inscribed in the rotunda of the Cade Museum, lines from Tennyson's Ulysses read: 'I am a part of all that I have met; Yet all experience is an arch wherethrough Gleams that untraveled world, whose margin fades... forever when I move.' For Miles, the poem illustrates that the next great adventure awaits. 'Rather than lamenting the passing of youth, I find it more exciting to embrace the experiences that come with each passing year. It is these experiences that provide the broad and deep foundation for all future accomplishments. My advice for anyone nearing the half-century mark is that your most significant contributions are likely to be ahead of you, not behind you!' For the full list visit: The Cade Museum for Creativity and Invention in Gainesville, Florida, is committed to transforming communities by inspiring and equipping future inventors, entrepreneurs, and visionaries. Named after Dr. James Robert Cade, the lead inventor of Gatorade, the project began in 2006 with a generous gift from Dr. Cade and his wife, Mary Cade. Led by their daughter, Phoebe Cade Miles and her husband, Richard Miles, the museum began educational programming and the Cade Prize in 2010. Since opening in 2018, more than 245,000 visitors have experienced the Cade's unique hands-on programming. For more information visit
Newsweek
26 minutes ago
- Newsweek
Costco Recall Update Nationwide as Fatal Warning Issued
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Costco, one of America's largest warehouse retailers, recently alerted consumers to several nationwide product recalls—including warnings classified as potentially fatal. The recalls include pools and food sold by the retail giant, affecting customers across the United States. Why It Matters According to the U.S. Food and Drug Administration (FDA), foodborne illness outbreaks and unsafe consumer goods remain leading causes of preventable hospitalizations and injuries in the U.S. A Costco store is seen on September 23, 2022 in Monterey Park, California. A Costco store is seen on September 23, 2022 in Monterey Park, California.) What To Know The following products sold at Costco were recalled in July: Pura announced a voluntary corrective action for certain Pura 4™ diffusers after discovering that magnets inside the front cover may detach over time. While no injuries have been reported, detached magnets can pose serious health risks if swallowed, particularly for children or pets. In response, Pura is offering free replacement covers to consumers with affected units. Users can continue using the diffuser by removing and safely discarding the current cover while waiting for the replacement. Pura advises keeping the diffuser out of reach of children and animals during this interim period. Customers can confirm if their diffuser is impacted and request a free replacement cover by visiting Support is also available at 855-394-5292 or via email at replacement@ The company emphasized its ongoing commitment to customer safety. Bestway, in cooperation with the U.S. Consumer Product Safety Commission, has issued a safety recall for select Power Steel, Steel Pro, and Coleman Power Steel aboveground pools sold between 2008 and 2024. The recall targets 48-inch or taller models with external compression straps, which children may use as footholds to access the pool unsupervised—posing a significant drowning risk. Affected products include item numbers sold through Costco between 2017 and 2024, such as 1099149, 1179351, 1274360, and others listed in the recall notice. Pools with internal straps or heights under 48 inches are not impacted. Customers are urged to verify if their pool is affected by checking strap placement and visiting to request a free, easy-to-install repair kit. In the meantime, pool access should be strictly controlled. For assistance, call 844-593-4003 or email BWrecallsupport5516@ Intex Recreation issued a voluntary recall of select aboveground pools 48 inches and taller, sold between 2002 and 2012, due to a potential drowning hazard. The affected models feature exterior compression straps that can serve as a foothold for children, enabling unsupervised pool access. The recall includes 48" and 52" Metal Frame and Ultra Frame pools, as well as certain Costco-sold models. Pools manufactured from 2013 onward are not impacted, as they use an internal strap system to eliminate the hazard. Customers are urged to visit or call 1-800-549-8829 to determine if their pool is affected and request a free repair kit. Until repaired, pool access should be strictly restricted or the pool drained. Intex also advises following the U.S. Consumer Product Safety Commission's Pool Safely guidelines to prevent accidents. Mondelēz Global issued a voluntary recall of a limited number of 40-count cartons of RITZ Peanut Butter Cracker Sandwiches, sold at select Costco Warehouses and Business Centers between June 2 and July 9, 2025. The recall affects cartons that may contain peanut butter cracker sandwiches but are incorrectly labeled as the cheese variety on the individual packs. While the outer cartons are correctly labeled and carry an allergen warning for peanuts, the mislabeling on individual wraps poses a serious risk for those with peanut allergies. The recalled items can be identified by Best When Used By dates ranging from November 1, 2025, to January 22, 2026, printed on the top of the package. Consumers with peanut allergies are urged not to consume the product and should return it to Costco for a full refund. Questions can be directed to Mondelēz at 1-844-366-1171, available 24/7. Members and the general public can reference Costco's official recall webpage for updates and expanded details.
